PNRC2 抗体 (AA 71-120)
Quick Overview for PNRC2 抗体 (AA 71-120) (ABIN6745134)
抗原
See all PNRC2 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 71-120
-
特异性
- Human PNRC2
-
预测反应
- Percent identity by BLAST analysis: Human, Zebrafish (100%) Mouse, Rat, Bovine, Chicken (92%).
-
纯化方法
- Immunoaffinity purified
-
免疫原
-
Synthetic peptide located between aa71-120 of human PNRC2 (Q9NPJ4, NP_060231). Percent identity by BLAST analysis: Human, Gorilla, Gibbon, Monkey, Marmoset, Rabbit, Guinea pig, Xenopus, Zebrafish (100%), Mouse, Rat, Elephant, Panda, Bovine, Horse, Opossum, Zebra finch, Chicken (92%).
Type of Immunogen: Synthetic peptide
-
-
anti-Proline Rich Nuclear Receptor Coactivator 2 (PNRC2) (AA 1-139) antibody
PNRC2 适用: 人 ELISA, WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Proline Rich Nuclear Receptor Coactivator 2 (PNRC2) antibodyPNRC2 适用: 人, 大鼠, 小鼠 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Proline Rich Nuclear Receptor Coactivator 2 (PNRC2) (N-Term) antibodyPNRC2 适用: 人, 大鼠, 兔, 马, 猴 WB 宿主: 兔 Polyclonal unconjugated
anti-Proline Rich Nuclear Receptor Coactivator 2 (PNRC2) (AA 1-100) antibodyPNRC2 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-Proline Rich Nuclear Receptor Coactivator 2 (PNRC2) (N-Term) antibodyPNRC2 适用: 人, 大鼠 WB 宿主: 兔 Polyclonal unconjugated
anti-Proline Rich Nuclear Receptor Coactivator 2 (PNRC2) (N-Term) antibodyPNRC2 适用: 人, 大鼠, 小鼠, 兔, 豚鼠, 马, Cow, 犬, Pig WB 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
-
Approved: WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody. -
说明
-
Target Species of Antibody: Human
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Distilled water
-
浓度
- Lot specific
-
缓冲液
- Lyophilized from PBS with 2 % sucrose
-
注意事项
- Avoid repeat freeze-thaw cycles.
-
储存条件
- 4 °C,-20 °C
-
储存方法
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
-
